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Focal adhesion kinase (FAK) has a central role in adhesion-
mediated cell signalling. The N-terminus of FAK is thought to
function as a docking site for a number of proteins, including the
Src-family tyrosine kinases. In the present study, we disrupted
FAK signalling by expressing the N-terminal domain of FAK
(FAK-NT) in human breast carcinoma cells, BT474 and MCF-7
lines, and non-malignant epithelial cells, MCF-10A line. Expres-
sion of FAK-NT led to rounding, detachment and apoptosis in hu-
man breast cancer cells. Apoptosis was accompanied by dephos-
phorylation of FAK Tyr397, degradation of the endogenous FAK
protein and activation of caspase-3. Over-expression of FAK
rescued FAK-NT-mediated cellular rounding. Expression of
FAK-NT in non-malignant breast epithelial cells did not lead
to rounding, loss of FAK phosphorylation or apoptosis. Thus
FAK-NT contributes to cellular adhesion and survival pathways
in breast cancer cells which are not required for survival in non-
malignant breast epithelial cells.
Key words: apoptosis, breast cancer cell, caspase activation,
protein degradation.
INTRODUCTION
Focal adhesion kinase (FAK) is a 125 kDa protein tyrosine
kinase localized to focal adhesions [1,2], which are sites of
cellular interactions with the extracellular matrix. FAK was
first identified in v-src-transformed fibroblasts as a tyrosine
phosphorylated protein [3] that co-precipitated with v-Src
[4]. Tyrosine phosphorylation of FAK occurs in response to
clustering of integrins [5], during formation of focal adhesions
and cell spreading [1,6,7]. In addition, FAK can be tyrosine
phosphorylated by other stimuli, such as bombesin [8], platelet-
derived growth factor [9] and hepatocyte growth factor [10,11].
FAK associates with a number of key signalling proteins,
including phosphoinositide 3-kinase [12], p130CAS [13,14] and
growth-factor-receptor-bound protein (Grb)2 [15,16], suggesting
that it may function as a switchable adaptor protein, recruiting or
anchoring proteins to focal adhesions.
We previously identified the human homologue of FAK in a
PCR-based screen for protein kinases expressed in high-grade
sarcomas [17]. FAK is over-expressed in breast, colon and thyroid
tumours, as well as sarcomas, and FAK is amplified in human tu-
mours [19]. FAK plays an essential role in tumour cell adhesion
[18], as well as survival, because interruption of FAK function
by antisense oligonucleotides led to irreversible loss of adhesion
and viability [20]. FAK has been proposed to be part of a survival
signalling pathway in normal cells [21–23] and has an association
with cell motility [24,25].
The FAK protein consists of a highly conserved catalytic
domain flanked by large N- and C-terminal domains. Most
of the studies relating to FAK function have focused on the
C-terminal domain. FAK-related non-kinase (FRNK) is a product
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of the FAK gene generated by an alternative transcriptional start
site within an intron [26]. The protein product of the FRNK
transcript corresponds to the C-terminal domain of FAK [27].
FRNK contains the focal adhesion targeting sequence [28] and
localizes to focal contacts where it acts as a negative regulator of
FAK function [29]. The C-terminal domain of FAK is a crucial
mediator of its localization and survival function in tumours.
When the same C-terminal region of the human FAK protein
was ectopically expressed in BT-474 breast cancer cells, it
caused irreversible loss of adhesion and viability, as well as a
corresponding decrease in FAK tyrosine phosphorylation [20].
In a similar fashion, adenovirus-mediated expression of the C-
terminus of FAK induced apoptosis in breast cancer cells [30,31].
The N-terminal domain of FAK has been implicated in cell
signalling, largely through its stimulation by integrin activation.
This domain contains the putative binding site for integrins,
and the FAK N-terminus binds to peptides mimicking the β1-
integrin cytoplasmic domain [32], suggesting that integrins could
interact directly with FAK. However, this interaction has not been
demonstrated in vivo, and it is also possible that FAK binds
indirectly to integrins through an interaction between the FAK
C-terminus and talin ([33] and reviewed by Cary and Guan [7]).
The N-terminal region of FAK contains the major autophosphoryl-
ation site, Tyr397 [34], which would point to an important role
of this domain in the functions of FAK. Phosphorylated Tyr397
creates a binding site for the Src homology 2 (SH2) domain of
Src-family kinases [34], including Fyn [13], phosphoinositide 3-
kinase [35], phospholipase C-γ 1 [36] and Grb7 [37]. The proline-
rich sequence at amino acids 368–377 (RALPSIPKAN), proximal
to the Tyr397, stabilizes the interaction of FAK with Src through
an SH3 domain interaction [36].
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In the present study, we have examined the effect of expressing
the N-terminus of FAK (FAK-NT) in human breast cancer
cells. Transient transfection of FAK-NT caused an early and
transient rounding of the breast cancer cells, while adenoviral
infection of FAK-NT led to cellular rounding, loss of FAK
tyrosine phosphorylation and apoptosis. The same pathway was
not affected in non-transformed MCF10A breast epithelial cells,
suggesting that the N-terminal region of FAK directs an adhesion
response that is required for breast cancer cell survival, but not
for non-transformed breast epithelial cells.
EXPERIMENTAL
Cell lines and culture
BT-474 human breast carcinoma cells were obtained from the
A.T.C.C. BT-474 cells were cultured in RPMI 1640 medium
(Gibco BRL) supplemented with 10 µg/ml insulin and 10 %
fetal bovine serum. MCF7 cells were cultured in Eagle’s minimal
essential medium containing 10 % fetal bovine serum, 10 µg/ml
insulin, 1 mM sodium pyruvate and 0.1 mM non-essential amino
acids. Cells were transfected with pUse-Src, selected for the
pUse vector and maintained in medium containing 400 µg/ml of
G418.
Plasmid constructions
The 1268-bp fragment corresponding to the FAK-NT sequence
was amplified from the full-length FAK cDNA by PCR.
The primers used were 5′-ACCGGTACCTCATGGCAGCTG-
CTTACCTTG-3′ and 5′-CATGGGCCCGTTCTATTCTTTCTC-
TTTG-3′. The amplified product was digested with KpnI and ApaI,
and ligated into the pEGFP-N1 plasmid (ClonTech, Palo Alto, CA,
U.S.A.). DNA was purified using a Qiagen plasmid purification
kit (Qiagen, Chatsworth, CA, U.S.A.), and the sequence identity
was confirmed by Taq FS Dye Terminator sequencing (Automated
DNA Sequencing Facility, University of North Carolina at Chapel
Hill). The FAK-NT sequence used in the present study contains
the FAK N-terminus plus six amino acids of the FAK kinase
domain.
The Tyr397 → Phe (Y397F) substitution was created from a
full-length pcDNA3-FAK construct and was kindly provided by
Dr Xiong Li and Dr Shelton Earp (Lineberger Comprehensive
Cancer Center, University of North Carolina at Chapel Hill).
The Y397F FAK-NT mutant was generated from this construct
using the PCR protocol described above and named FAK-Y397F/
NT. After confirming the identity of the sequence, FAK-
Y397F/NT was cloned into the pEGFP-N1 vector. The plasmid
pcDNA3 containing the full-length haemagglutinin (HA)-tagged
FAK was used in the transient transfection experiments to over-
express exogeneous p125FAK in BT-474 cells.
The pShuttle HA-FAK-NT was constructed by subcloning the
PCR-amplified FAK-NT from pcDNA3 HA-FAK into the KpnI
and HindIII sites of the pShuttle-CMV vector (Virus Vector
Core Facility, University of North Carolina at Chapel Hill). The
adenoviral pShuttle HA-FAK-NT was constructed by subcloning
the PCR-amplified FAK-NT from pcDNA3 HA-FAK into the
KpnI and HindIII sites of the pShuttle-CMV vector (Virus Vector
Core Facility). The recombinant virus containing FAK-NT, called
Ad-FAK-NT, was used for adenoviral infections as described
previously [30].
The pUse/c-src construct (Upstate Biotechnology, Lake Placid,
NY, U.S.A.), containing an activating Y529F mutation of murine
c-Src, was stably transfected using standard techniques. These
cells were characterized and shown to over-express c-Src and
possess Src-kinase activity (results not shown). In addition, the
pUse host vector was stably transfected as a control.
Transfections and infections
For transient transfection, 1 × 105 cells were plated on to cover-
slips in six-well plates or 1.5 × 106 were plated on to
100-mm tissue culture dishes for 24 h. Cells were then transfected
with a 1 : 3 ratio of DNA and LIPOFECTAMINETM (Life
Technologies) for 8 h. The transfection mixture was removed and
replaced with medium containing serum at various time intervals.
Cells on coverslips were washed with PBS, fixed in 2 %
paraformaldehyde and mounted on slides. Cell morphology was
observed by fluorescence microscopy; round transfected cells
were counted and photomicrographs were obtained using a Zeiss
fluorescence microscope.
For infections, cells were plated at 1 × 106 per 100-mm culture
plate for 24 h and infected with Ad-FAK-NT or Ad-LacZ control
adenovirus, carrying the lacZ gene, expressing β-galactosidase
[kindly provided by Dr J. Samulski (Virus Vector Core Facility)].
Cells were infected at different doses and expression of FAK-NT
was verified by Western blotting using anti-HA and anti-FAK
antibodies.
Antibodies
The anti-[green fluorescent protein (GFP)] monoclonal antibody
was purchased from ClonTech, and the anti-FAK monoclonal
antibody 4.47, recognizing an epitope within amino acids 1–423
of FAK, and the kinase domain-specific antibody were purchased
from Upstate Biotechnology, whereas the anti-(phospho-Tyr397-
FAK) antibody was from Biosource International. The other
antibodies used in this study were the anti-phosphotyrosine
antibody 4G10 (Upstate Biotechnology), the monoclonal anti-
vinculin (clone VIN-11–5) antibody (Sigma), the anti-HA
antibody HA11 (BabCO, Richmond, CA, U.S.A.), and mono-
clonal antibodies to β-actin (Sigma) and inactive caspase-3
(Transduction Laboratories).
Immunofluorescence microscopy
Cells were plated on to uncoated coverslips in six-well culture
plates in serum-containing medium for 24 h, transfected with
the GFP or GFP-FAK-NT constructs, as described above, and
then stained for vinculin 16–24 h later. Rhodamine-conjugated
anti-mouse secondary antibodies were used where indicated.
Conditions for immunofluorescence and measurement of apop-
tosis have been described previously [30].
Immunoprecipitation and Western-blot analysis
BT-474 cells transfected with the GFP or GFP-FAK-NT
constructs were harvested with trypsin and EDTA, washed
twice in Hanks balanced salt solution, and lysed in suspension
in 1% Nonidet P-40 lysis buffer (20 mM Tris, pH 7.5,
150 mM NaCl and 0.5 mM EDTA) containing 0.1 mM Na3VO4
and a cocktail of protease inhibitors. The protein concentrations
of the lysates were determined using the bicinchoninic acid
assay (Pierce Chemical, Rockford, IL, U.S.A.). Equal amounts
of protein were immunoprecipitated with anti-FAK rabbit
polyclonal antibody in the presence of Protein G Plus/Protein A–
agarose (Oncogene Research Products, Cambridge, MA, U.S.A.).
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Figure 1 Morphological rounding induced by expression of FAK-NT in BT-474 breast cancer cells
(A) Cells were transiently transfected with GFP or GFP-FAK-NT constructs, fixed and observed by fluorescence microscopy. At the time point of 24 h, GFP-FAK-NT transfectants showed a rounded
morphology. Left panels, GFP-transfected cells; right panels, GFP-FAK-NT-transfected cells; upper panels, phase contrast image; middle panels, GFP-expressing cells under the FITC filter; lower
panels, vinculin–Rhodamine immunostaining. Arrows indicate round FAK-NT-expressing cells with lost focal adhesions detected by the absence of vinculin in contrast with the control GFP-expressing
cells. (B) FACS-sorted cells transfected as in (A). The selected fluorescent population was replated on coverslips in the serum containing medium for an additional 24 h. FAK-NT cells remained
rounded compared with the GFP-expressing control cells. (C) Western-blot analysis of FAK-NT expression. BT-474 cells were lysed 24 h after transfection with GFP or GFP-FAK-NT plasmids. Equal
amounts of cell lysate were subjected to Western-blot analysis with anti-GFP or anti-(FAK-NT) monoclonal antibodies. The level of FAK expression remained relatively constant at 48 h.
Immunoprecipitated samples were resolved by SDS/PAGE (7.0%
gel) and transferred on to PVDF membrane. Blots were blocked
with a 3% BSA/0.1% Tween/TBS solution and blotted with
anti-phosphotyrosine monoclonal antibody (4G10). Blots were
also stripped and reprobed with an anti-(FAK-NT) monoclonal
antibody to control for loading. The immunoreactive bands were
detected with the ECL R© detection system.
Cell rounding assay
Cells were transiently transfected with the GFP or GFP-FAK-NT
constructs, fixed at different time points after transfection and
observed by fluorescent microscopy. The percentage of rounded
cells was determined by dividing the number of rounded GFP-
or GFP–FAK-NT-expressing (green) cells by the total number
of GFP-expressing green cells. For some experiments, cells were
harvested 24 h after transfection and sorted by FACS analysis.
The selected fluorescent population of cells was replated in
medium with 10% FBS for 24 h and observed for rounded
morphology.
RESULTS
For these experiments, the first 423 amino acids of FAK were
fused in frame with GFP in the plasmid pEGFP-N1/FAK-NT. BT-
474 human breast cancer cells were transiently transfected with
pEGFP-N1 vector (GFP) or pEGFP-N1/FAK-NT plasmid (GFP-
FAK-NT), and then observed under the fluorescence microscope
after incubation at 37 ◦C for various time periods. The transfection
efficiency was consistently 20–25% for cells transfected with
either the GFP or GFP-FAK-NT construct. From 2.5 to 24 h
following transfection, GFP–FAK-NT-expressing BT-474 cells
developed a rounded morphology (Figure 1A and Table 1).
Rounded GFP-FAK-NT-transfected cells lost focal adhesion
formation, as detected by vinculin staining (Figure 1A, right lower
panel), in contrast with GFP-expressing cells (Figure 1A, left
lower panel). To increase the number of transfected cells, we
analysed the morphology of GFP- and GFP–FAK-NT-expressing
cells sorted by FACS and 24 h post-transfection. As before,
we observed rounding among GFP–FAK-NT-expressing cells
compared with GFP-expressing cells (Figure 1B). Expression
of the 80 kDa GFP–FAK-NT protein was assessed by Western
blotting using both anti-GFP and anti-FAK N-terminal antibodies
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Table 1 Induction of cellular rounding in BT-474 breast cancer cells by
GFP–FAK-NT
Cells were transfected with the GFP or GFP-FAK-NT constructs and the percentages of round
transfected cells were determined at different time points post-transfection by fluorescence
microscopy. Results are expressed as the means +− S.D. *P < 0.05, **P < 0.01; Student’s t test.
All experiments were repeated more than five times with the same result, and the representative
experiments are shown in the Table. For each experiment more than 100 cells were counted in
more than three independent fields. The percentage of rounded cells was determined by dividing
the number of round GFP- or GFP-FAK-NT-expressing (green) cells by the total number of green
cells, which expressed GFP plasmids.
Rounded cells (%)
Experiment 1 Experiment 2
Plasmids 2.5 h 4 h 8 h 24 h
GFP 14.6 +− 8.9 19 +− 6.0 29.6 +− 8.8 22.5 +− 6.4
GFP–FAK-NT 43.3 +− 9.8* 36.4 +− 9.3* 51.6 +− 11.0* 54.7 +− 12.4*
(Figure 1C). FAK-NT-mediated rounding was not specific
to BT474 cells, because GFP–FAK-NT induced rounding in
40 +− 11% of SK-BR-3 breast carcinoma cells. By comparison,
GFP alone induced 15 +− 6% rounding in these cells.
To rule out the possibility that GFP itself contributed to the
effect of FAK-NT, we made an HA-tagged FAK-NT construct by
subcloning FAK-NT into the pShuttle-CMV expression vector.
We transfected the pShuttle HA-FAK-NT into BT-474 cells,
and the cells expressing pShuttle HA-FAK-NT showed a similar
percentage of rounding (38 +− 10%) as that induced by GFP–
FAK-NT, demonstrating that cellular rounding induced by
GFP–FAK-NT was not due to the GFP fusion partner.
We hypothesized that FAK-NT-mediated cell rounding resulted
from competition for binding sites between endogenous FAK
and exogenous FAK-NT. If so, over-expression of p125FAK might
reverse the rounding effect induced by FAK-NT. To test this,
BT474 cells were transiently co-transfected with the GFP-FAK-
NT and pcDNA3-HA-FAK constructs at a 1 : 3 ratio. As expected,
FAK over-expression prevented GFP–FAK-NT-mediated cellular
rounding, whereas cells transfected with GFP-FAK-NT construct
and a control plasmid rounded (Figure 2A). Cells expressing
HA-tagged FAK and either GFP or GFP–FAK-NT (Figure 2B,
middle panels) were stained with an antibody to HA, and in
both cases exogenous full-length FAK protein localized to the
cell periphery (Figure 2B, right panels). Furthermore, FAK over-
expression preserved normal spread cell morphology and normal
focal adhesion organization (Figure 2B, left panels). Expression
of exogenous HA-tagged FAK and GFP-FAK-NT plasmids was
also demonstrated by Western-blot analysis (Figure 2C).
Because FAK and c-Src physically associate through a site
in the N-terminus of FAK, we tested whether BT-474 cells
expressing a constitutively active mutant of c-Src were sensitive to
the transient rounding induced by FAK-NT (Figures 2D–2F). BT-
474 cells were transfected with the pUse vector or pUse containing
activated murine c-Src, and stably over-expressing clones were
identified (Figure 2F). Whereas the pUse vector control cells
transfected with the constructs for GFP-FAK-NT or GFP-FAK-
Y397F-NT mutant showed significant rounding (Figure 2D), the
activated c-Src-over-expressing cells transfected with GFP-FAK-
NT vector had a very low percentage of rounding (Figure 2D),
similar to the level shown by BT-474 cells transfected with GFP
vector. Expression of both the GFP–FAK-NT and GFP–FAK-NT-
Y397F proteins was verified by Western blotting (Figure 2E), and
we also detected absence of Tyr397 phosphorylation in the GFP–
FAK-NT-Y397F mutant (results not shown). Thus activated c-Src
is capable of conferring resistance to the induction of the rounded
phenotype induced by FAK-NT and FAK-NT-Y397F vectors in
BT-474 cells.
The N-terminal Tyr397 of FAK is a binding site for a number
of kinase SH2 domains, and the interaction of the Src family of
kinases with this site has been extensively characterized [34,38].
Mutation of Tyr397 to Phe in the GFP-FAK-NT construct did
not affect FAK-NT-mediated cellular rounding, and the ability
of GFP–FAK-NT-Y397F to induce rounding was completely
suppressed by activated Src (Figure 2D). We conclude that
FAK-NT does not affect cellular adhesion exclusively through
Tyr397-mediated interactions, and that Src does not suppress
FAK-NT-mediated cellular rounding by binding to Tyr397.
Transient transfections are limited by the low efficiency of
transfection (5–27% for most of these experiments) and the
toxicity of the transfection procedure. To increase transfer
efficiency, we developed an adenovirus directing expression of
FAK-NT fused in frame with an HA-epitope tag sequence.
Infection of BT474 cells with Ad-FAK-NT caused cellular
rounding similar to the transient transfection procedure used
above (Figure 3A, right upper and middle panels), in contrast with
cells infected with Ad-LacZ (Figure 3A, left upper and middle
panels).
FAK generally localizes to focal adhesions in BT474 cells, with
a significant fraction localized in a diffuse manner throughout
the cytoplasm and nucleus. This localization was not affected
by the Ad-LacZ control virus (Figure 3A, lower left panel). In
contrast, infection of BT474 cells with Ad-FAK-NT displaced
FAK from focal adhesions (Figure 3A, lower right panel).
Intriguingly, FAK-NT appeared to have significant nuclear
localization in BT474 cells (Figure 3A, middle panel), consistent
with previous studies in other cell lines [39–41].
Breast cancer cell lines are genetically unstable and vary
greatly in biological responses. For that reason, we tested the
MCF-7 breast cancer cell line for rounding after infection with
Ad-FAK-NT. As in BT474 cells, MCF-7 cells infected with Ad-
FAK-NT demonstrated localization of FAK-NT to the nucleus
with subsequent rounding and detachment from the dish
(Figure 3B, right upper and middle panels) in contrast with Ad-
LacZ-infected MCF-7 cells (Figure 3B, left upper and middle
panels). Infection with Ad-FAK-NT led to displacement of FAK
from focal adhesions (Figure 3B, lower right panel). BT474 and
MCF-7 cells infected with Ad-FAK-NT expressed high levels of
HA-tagged FAK-NT protein (Figure 3C).
Displacement of FAK from focal adhesions led to the
degradation of FAK in BT474 cells infected with Ad-FAK-NT
(Figure 4A, upper panel). In MCF-7 cells, FAK-NT-mediated
regulation of FAK was more complex. At the 125 focus-forming
unit (ffu)/cell viral dose, FAK became dephosphorylated and FAK
was partially degraded (Figure 4B), and at higher doses FAK was
degraded (Figure 4B). Because Tyr397 is a key binding site for a
number of proteins to the N-terminus of FAK, we analysed the
phosphorylation of Tyr397 following Ad-FAK-NT infection, and
as expected, FAK Tyr397 became dephosphorylated and FAK was
degraded with increased doses of Ad-FAK-NT (Figure 5A, upper
and middle panels) in BT474 cells and similarly in MCF-7 cells
(Figure 5B, upper and middle panels).
Degradation of FAK accompanies apoptosis and may contribute
to apoptotic progression. Cleaved forms of FAK appeared in a
time- and adenoviral dose-dependent manner, following infection
with Ad-FAK-NT in BT-474 cells (Figures 4A and 5A, middle
panels) and in adenoviral dose-dependent manner in MCF-7 cells
(Figures 4B and 5B, middle panels). We found that Ad-FAK-NT
led to activation of caspase-3 in BT474 cells, a key step in
apoptotic progression (Figure 5A, third panel) and caused an
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Figure 2 Reversal of FAK-NT-mediated cell rounding by over-expression of full-length FAK or activated c-Src
BT474 cells were transfected with a GFP control vector (open bars) or GFP-FAK-NT construct (closed bars) and observed microscopically 24 h later. (A) Cellular rounding mediated by GFP–FAK-NT
was reversed by over-expression of the full-length FAK protein by co-transfection with the pcDNA3 HA-FAK 24 h post-transfection. All experiments were done in triplicate, and repeated > 3
times with the similar results, as described in Table 1. The average percentage of rounding +− S.D. are shown. (B) Expression of HA–FAK and GFP proteins. BT474 cells were transfected with
HA-tagged FAK-pcDNA3 plasmid and either GFP (upper panels) or GFP-FAK-NT (lower panels) vectors. Left panels, phase contrast images of cells. Expression of the GFP proteins was assessed
by GFP fluorescence (middle panels) or immunofluorescence with an anti-HA antibody (right panels). Expression of the full-length HA-FAK proteins suppressed FAK-NT-mediated cell rounding
(phase contrast images). (C) Western-blot analysis (WB) of GFP–FAK-NT and HA–FAK protein expression. Presence of transfected plasmid is indicated by plus ( + ) and absence by minus ( − ).
Untransfected cells are shown in lane 1. Cells were transfected either with GFP + pcDNA3 control vector (lane 2), GFP-FAK-NT + pcDNA3 vector (lane 3) or GFP-FAK-NT + pcDNA3-HA-FAK
vectors (lane 4). Cell lysates were analysed 24 h post-transfection by immunoprecipitation (IP) with anti-FAK antibody, and probed first with anti-HA tag antibody (upper panel), then stripped and
re-probed with anti-FAK antibody (lower panel). Transfected cells expressed high levels of HA–FAK and GFP–FAK proteins 24 h after transfection. (D) Transfection of GFP-FAK-NT into a BT474 line
over-expressing activated c-Src did not induce cellular rounding. Because FAK and Src associate physically via the Tyr397 of FAK, the GFP-FAK-NT-Y397F was tested to see whether it induced cellular
rounding. Transfection of the GFP-FAK-NT-Y397F mutant (closed bars) caused cellular rounding to a similar extent found in the wild-type protein (grey bars), as compared with GFP protein (open
bars), and rounding induced by the GFP-FAK-NT-Y397F construct was completely reversed by activated Src. Rounding was analysed at 24 h post-transfection in several independent experiments
with the same result, as described in Table 1. The representative experiment is shown. The results are expressed as the average percentage of rounding +− S.D. (E) Expression of GFP–FAK-NT and
GFP–FAK-NT-Y397F by Western blotting. At 24 h post-transfection, BT474 cells were collected and analysed with an anti-FAK antibody. Equal protein loading was analysed with anti-(β-actin)
antibody. (F) Expression of activated c-Src was examined by Western blotting with an anti-Src antibody. BT-474-Src cells expressed high levels of Src protein. Equal amounts of protein were loaded
on to the gel.
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increase in apoptosis (Table 2). As in BT474 cells, there was
a marked increase in the percentage of apoptotic MCF7 cells
following Ad-FAK-NT infection, but not in control Ad-LacZ-
infected cells (Table 2). We conclude that the FAK N-terminus
regulates adhesion and suppresses apoptosis in multiple breast
cancer cell lines.
Because FAK-NT over-expression led to loss of adhesion in
breast cancer cells, we determined whether this was a general
property of breast epithelial cells. MCF10A cells are derived from
breast with fibrocystic disease and are a relatively normal cell line.
Infection of MCF10A cells did not cause cellular rounding, even
though FAK-NT was readily detectable (Figure 5C). MCF10A
cells infected with Ad-FAK-NT maintained normal levels of
phosphorylation of Tyr397 (Figure 5C, upper panel) and FAK was
not degraded (Figure 5C, second panel).
In addition, we did not detect any increase in the percentage
of apoptotic cells in MCF10A cells (Table 2) or activation of
caspase-3 following infection with Ad-FAK-NT (Figure 5C, third
panel). Interestingly, FAK-NT underwent a different degree of
processing in MCF10A (Figure 5C, second panel) compared with
BT474 and MCF-7 cells (Figures 5A and 5B respectively, middle
panels). It is possible that the altered electrophoretic mobility
of FAK-NT in these cells underlies its distinct functions in
non-transformed and cancer cell lines. Normal MCF-10A cells
infected with Ad-FAK-NT remained spread (Figure 5D, upper
panels) with FAK localized throughout the cytoplasm (Figure 5D,
lower panels) and at the focal adhesions (results not shown). FAK-
NT was localized in a diffuse pattern mainly in the cytoplasm
(Figure 5D, middle panels). We conclude that FAK-NT serves in
the maintenance of adhesion and apoptosis in tumour cells, but
is not required for adhesion in non-transformed breast epithelial
cells. We also present a model of FAK-NT-induced apoptosis in
cancer cell lines (Scheme 1).
DISCUSSION
We have shown that over-expression of the FAK N-terminal
domain induces rounding, detachment and apoptosis in breast
cancer cell lines. This finding coincides with our previous work
with the FAK C-terminal domain in which over-expression of
the FAK C-terminus caused loss of adhesion [42] and apoptosis
[30,31] in breast cancer cell lines. These results are all consistent
with a role of FAK in cell survival signalling [22,23,30,42–46].
Survival signalling is a central pathway in cancer progression.
As epithelial cells proliferate and begin to invade their surrounding
substratum, it is necessary to suppress the apoptotic signals
associated with loss of cell–cell contact. FAK is a key mediator of
survival signalling, perhaps functioning by amplifying a surrogate
Figure 3 Adenoviral transduction of FAK-NT induces cellular rounding
(A) BT474 cells were infected with a control adenovirus (Ad-LacZ) or an adenovirus containing
FAK-NT (Ad-FAK-NT) at a dose of 125 ffu/cell and grown for 16 h. Infected cells expressing
the HA-tagged FAK-NT (HA immunofluorescence on the right middle panel) underwent cellular
rounding (right upper panel), while endogenous FAK was displaced from the focal adhesions
(demonstrated with FAK kinase domain-specific antibody, right lower panel). Cells infected with
a control adenovirus did not undergo rounding (left upper panel), were not immunoreactive for
HA (left middle panel), and expressed FAK at the focal adhesion contacts at the cell periphery (left
lower panel). (B) Infection of MCF7 breast cancer cells with Ad-FAK-NT causes cellular rounding.
MCF7 cells were infected with 500 ffu/cell of Ad-LacZ control or Ad-FAK-NT adenoviruses and
grown for 16 h. Cells were visualized by bright field (upper panels), immunofluorescence with
an antibody to HA (middle panels), and a FAK kinase domain-specific antibody (lower panels).
Infection with Ad-FAK-NT caused cellular rounding (right upper panel) that corresponded with
HA–FAK-NT expression (right middle panel), and displacement of endogenous FAK from focal
adhesions (compare left and right lower panels). (C) Western blot (WB) showing expression of
HA–FAK-NT protein following infection into BT474 and MCF7 breast cancer cell lines.
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Figure 4 FAK tyrosine phosphorylation is diminished in cells infected with
Ad-FAK-NT
(A) FAK was immunoprecipitated from BT474 cells infected with the Ad-FAK-NT adenovirus
and analysed for expression (middle panel) and total tyrosine phosphorylation (upper panel).
FAK tyrosine phosphorylation decreased dramatically within 24 h of infection, while FAK
phosphorylation was much less affected in cells expressing a control Ad-LacZ adenovirus
(Lac Z lanes). Decreased FAK tyrosine phosphorylation correlated with degradation of the
FAK protein (middle panel). During the same time course, expression of the exogenous FAK-NT
protein increased (lower panel). (B) FAK was immunoprecipitated from MCF7 cells infected
with increasing amounts of Ad-LacZ control or Ad-FAK-NT adenoviruses and analysed by
Western blotting for FAK expression (middle panel) or tyrosine phosphorylation (upper panel).
Ad-FAK-NT expression led to loss of FAK tyrosine phosphorylation (upper panel) and the
appearance of lower molecular mass FAK degradation products (middle panel). A Western blot
of FAK demonstrates FAK-NT expression with increasing doses of adenovirus (lower panel). IP,
immunoprecipitation; MW, molecular-mass markers; PTyr, phosphotyrosine; WB, Western blot.
adhesion signal, even as invading cells are deprived of cell–cell
contact. Indeed, we have shown that cultured breast cancer
cells deprived of adhesion to a culture dish are viable, but that
attenuation of FAK function leads to a dramatic increase in
apoptosis [30]. Whereas our previous work focused on the role
of the FAK C-terminus in survival signalling [30,31,42], the
present work indicates an equally important and novel role for
the FAK-NT, and the role of FAK-NT in apoptosis is proposed in
Scheme 1.
The molecular features of FAK required for survival signalling
are not known. Richardson et al. [47] analysed various mutants
of FAK for their ability to suppress loss of adhesion associated
with over-expression of the FRNK variant of the FAK C-terminal
domain. FAK over-expression suppressed loss of adhesion due
to FRNK expression, and this suppression was complete even in
kinase-deficient FAK mutants [47]. In contrast, loss of the
Table 2 Induction of apoptosis by infection with Ad-FAK-NT
Cells were infected with Ad-Lac-Z and Ad-FAK-NT (at a dose of 500 ffu/cell), and detection
of apoptosis was performed by TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labelling) assay. The percentage of apoptotic cells was determined by dividing the
number of apoptotic cells by the total number of cells following 23 h of adenoviral transduction.
Apoptotic cells were counted in three independent fields, where 100 cells per field were counted.
The experiments were performed two times with the same result. Results are expressed as the
means +− S.D. Infection of breast cancer cells with Ad-FAK-NT caused significant increase of
apoptosis.
Apoptotic cells (%)
Cell line Ad-LacZ Ad-FAK-NT
BT-474 0 56 +− 3.6
MCF-7 0 58 +− 4.0
MCF10A 0 0
Scheme 1 Model for FAK-NT induced rounding and apoptosis in breast
cancer cell lines
Tyr397 binding site negated the suppressive activity of FAK,
suggesting that Src binding was required for restoring adhesion
to FRNK-expressing cells [47]. Richardson et al. [47] concluded
that FAK acts as a ‘flexible adaptor’, bringing together the Src
tyrosine kinase with its substrate paxillin [47].
Our data are consistent with the ‘flexible adaptor’ model
because both the N- and C-terminal domains are capable of
disrupting the FAK survival function.
The N-terminus of FAK binds to a number of key signalling
proteins through its N-terminus, including Src [34], Grb7 [37],
phosphatidylinositol 3-kinase [35], and phospholipase C-γ 1 [48].
All of these proteins bind to Tyr397 upon phosphorylation, and
Tyr397 is required for FAK-mediated cell spreading [47,49].
However, our results differ from those of Richardson et al. [47]
because mutation of the Tyr397 to Phe did not affect the ability of
FAK-NT to induce cellular rounding. We conclude that proteins
other than those which bind to Tyr397 are important for FAK-NT-
induced cellular rounding, or that a subset of proteins which bind
to the FAK N-terminus can still bind in the absence of Tyr397. In
the latter case, one possible binding partner for FAK-NT is the
Src family of kinases, which also associate with an SH3 binding
site at amino acids 368–377 of FAK [36].
FAK is anchored to focal adhesions through a sequence in the
C-terminal region called the focal adhesion targeting sequence.
For that reason, we were surprised that FAK was displaced from
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Figure 5 Decreased tyrosine phosphorylation of Tyr397 of FAK corresponds with FAK degradation and increased caspase-3 activation in breast cancer cell
lines
(A) Elevated dosage of Ad-FAK-NT adenovirus causes loss of FAK Tyr397 phosphorylation (125 kDa band, upper panel), FAK degradation (middle panel, 80 kDa band), and disappearance of the inactive
caspase-3 isoform (third panel). All analyses were Western blots of BT474 cells infected with increasing doses of Ad-LacZ or Ad-FAK-NT, as indicated, probed with antibodies to phosphorylated
FAK Tyr397, FAK, inactive caspase-3 or β-actin. (B) Infected MCF7 cells were lysed and probed with a phospho-specific FAK Tyr397 antibody, demonstrating loss of Tyr397 phosphorylation in
Ad-FAK-NT-infected cells, but not in Ad-LacZ-infected cells. (C) Infection of MCF10A breast epithelial cells with the Ad-FAK-NT adenovirus. MCF10A cells were infected with increasing doses
of the Ad-LacZ control or Ad-FAK-NT adenoviruses as indicated and lysed 24 h post-infection. Lysates from infected cells were analysed for FAK Tyr397 tyrosine phosphorylation (upper panel),
FAK and FAK-NT expression (second panel), caspase-3 inactive form degradation (third panel) and β-actin expression (lower panel). The Ad-FAK-NT adenovirus directed strong expression of
the FAK-NT protein (two upper panels), but did not affect cellular adhesion, FAK expression (second panel), FAK Tyr397 phosphorylation (upper panel), or caspase-3 inactive form activation (third
panel). (D) MCF10A cells were infected with a control adenovirus (Adeno-LacZ) or an adenovirus containing FAK-NT (Adeno-FAK-NT) at a dose of 500 ffu/cell and grown for 16 h. Infected cells
expressing the HA-tagged FAK-NT (HA immunofluorescence, right middle panel) did not undergo cellular rounding (right upper panel) and endogenous FAK was cytoplasmic [demonstrated with
FAK kinase domain-specific antibody (right lower panel)]. FAK-NT localized mainly in cytoplasm (right middle panel). Cells infected with a control adenovirus did not round (left upper panel), were
not immunoreactive for HA (left middle panel), and expressed FAK at the focal adhesions at the cell periphery (left lower panel).
focal adhesions by FAK-NT. A recent report [50] has found
a role for FAK-NT in directing localization of FAK to focal
adhesions. Our results are consistent with the model that there
is a second focal adhesion-targeting domain in the FAK-NT, and
that disruption of this domain leads to displacement of FAK from
focal adhesions and cancer cell apoptosis.
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FAK is over-expressed in a broad variety of tumours,
including breast tumours, suggesting a distinct role for FAK in
tumorigenesis. Indeed, expression of the FAK C-terminal domain
induced apoptosis in tumour cells, but not in non-transformed
breast epithelial cells [30]. Similarly, FAK-NT induced apoptosis
in cancer-derived cell lines, but not in non-transformed cells.
We conclude that the essential function of FAK in tumours is not
exclusively due to the C-terminus, but to the entire protein. Finally,
these results support our previous observations [42] that epithelial
tumour cells are more sensitive to the effects of interrupting FAK
signalling than their non-transformed counterparts. Indeed non-
transformed MCF-10 breast epithelial cells did not demonstrate
the round phenotype unless they were ras-transformed (results
not shown). Cancer cells often have morphological abnormalities
that correlate with detachment and apoptosis, leading to adhesion
independence and invasiveness, but normal cells can suppress
apoptosis, not only by adhesion to the extracellular matrix, but
also through distinct cell spreading morphology and integrity of
cytoskeleton differences, as was shown in MCF10A cells [51].
These cells required actin depolymerization agents in addition
to other apoptotic stimuli to cause apoptosis [51], which is in
contrast with cancer cell lines. These results demonstrate an
important role for the entire FAK protein in suppressing apoptosis
in human tumour cells, as shown in Scheme 1. Whereas the
C-terminus appears to localize FAK and mediate some aspects
of tumour cell survival, the N-terminus also appears to contribute
to the adhesive and apoptosis-suppressive functions of FAK. As
cells become transformed and migrate to distant sites, both the
N- and C-terminal domains may serve as excellent targets for
pharmaceutical intervention.
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